全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
化学进展  2013 

多肽介导的肿瘤靶向纳米递药系统

DOI: 10.7536/PC121050, PP. 1052-1060

Keywords: 多肽介导,纳米递药系统,肿瘤靶向,系统性靶向

Full-Text   Cite this paper   Add to My Lib

Abstract:

肿瘤靶向纳米递药系统是指利用肿瘤组织特殊的生理病理特点,由纳米载体包载肿瘤诊疗药物构建而成的对肿瘤组织具有靶向定位功能的药物递送系统。多肽介导的肿瘤靶向纳米递药系统是肿瘤靶向递药领域较新的一个研究方向,本文综述了该研究方向的四个重要发展历程--单功能靶向、双功能靶向、肿瘤穿透和环境响应型靶向纳米递药系统,并介绍了各类递药系统的设计原理和典型研究案例。此外,对目前多肽介导的纳米递药系统存在的优势与不足进行了分析。最后,针对当前主动靶向肿瘤递药系统存在的研究困境,提出了一种新型肿瘤靶向递药策略--“系统性靶向”策略。随着相关学科和多学科交叉的发展,多肽介导的肿瘤靶向纳米递药系统将在肿瘤治疗中扮演更为重要的角色。

References

[1]  Zhou Y, Kopecek J. J. Drug. Target., 2013, 21: 1-26
[2]  Gao H, Shi W, Freund L B. Proc. Natl. Acad. Sci. U. S. A., 2005, 102: 9469-9474
[3]  Dagar S, Krishnadas A, Rubinstein I, Blend M J, Onyuksel H. J. Control Release, 2003, 91: 123-133
[4]  Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W. J. Control Release, 2010, 143: 136-142
[5]  Holig P, Bach M, Volkel T, Nahde T, Hoffmann S, Muller R, Kontermann R E. Protein Eng. Des. Sel., 2004, 17: 433-441
[6]  Pastorino F, Brignole C, Marimpietri D, Cilli M, Gambini C, Ribatti D, Longhi R, Allen T M, Corti A, Ponzoni M. Cancer Res., 2003, 63: 7400-7409
[7]  Kondo M, Asai T, Katanasaka Y, Sadzuka Y, Tsukada H, Ogino K, Taki T, Baba K, Oku N. Int. J. Cancer., 2004, 108: 301-306
[8]  Yan Z, Wang F, Wen Z, Zhan C, Feng L, Liu Y, Wei X, Xie C, Lu W. J. Control Release, 2012, 157: 118-125
[9]  Yan Z, Zhan C, Wen Z, Feng L, Wang F, Liu Y, Yang X, Dong Q, Liu M, Lu W. Nanotechnology, 2011, 22: art. no. 415103
[10]  Xin H, Jiang X, Gu J, Sha X, Chen L, Law K, Chen Y, Wang X, Jiang Y, Fang X. Biomaterials, 2011, 32: 4293-4305
[11]  Mei D, Gao H, Gong W, Pang Z, Jiang X, Chen J. African Journal of Pharmacy and Pharmacology, 2011, 5: 409-414
[12]  Derfus A M, Chen A A, Min D H, Ruoslahti E, Bhatia S N. Bioconjug. Chem., 2007, 18: 1391-1396
[13]  Hu Q, Gu G, Liu Z, Jiang M, Kang T, Miao D, Tu Y, Pang Z, Song Q, Yao L, Xia H, Chen H, Jiang X, Gao X, Chen J. Biomaterials, 2013, 34: 1135-1145
[14]  Negussie A H, Miller J L, Reddy G, Drake S K, Wood B J, Dreher M R. J. Control Release, 2010, 143: 265-273
[15]  Moura V, Lacerda M, Figueiredo P, Corvo M L, Cruz M E, Soares R, de Lima M C, Simoes S, Moreira J N. Breast Cancer Res. Treat., 2012, 133: 61-73
[16]  Ruoslahti E, Bhatia S N, Sailor M J. J. Cell. Biol., 2010, 188: 759-768
[17]  Ran S, Volk L, Hall K, Flister M J. Pathophysiology, 2010, 17: 229-251
[18]  Primeau A J, Rendon A, Hedley D, Lilge L, Tannock I F. Clin. Cancer. Res., 2005, 11: 8782-8788
[19]  Teesalu T, Sugahara K N, Kotamraju V R, Ruoslahti E. Proc. Natl. Acad. Sci. U. S. A., 2009, 106: 16157-16162
[20]  Torchilin V. Eur. J. Pharm. Biopharm., 2009, 71: 431-444
[21]  Sawant R M, Hurley J P, Salmaso S, Kale A, Tolcheva E, Levchenko T S, Torchilin V P. Bioconjug. Chem., 2006, 17: 943-949
[22]  Bae Y H. J. Control Release, 2009, 133: 2-3
[23]  Lo A, Lin C T, Wu H C. Mol. Cancer Ther., 2008, 7: 579-589
[24]  Gu F, Zhang L, Teply B A, Mann N, Wang A, Radovic-Moreno A F, Langer R, Farokhzad O C. Proc. Natl. Acad. Sci. U. S. A., 2008, 105: 2586-2591
[25]  Ng C K, Pemberton H N, Reis-Filho J S. Expert. Rev. Anticancer. Ther., 2012, 12: 1021-1032
[26]  Zhan C, Zhao L, Wei X, Wu X, Chen X, Yuan W, Lu W Y, Pazgier M, Lu W. J. Med. Chem., 2012, 55: 6237-6241
[27]  Pujals S, Sabido E, Tarrago T, Giralt E. Biochem. Soc. Trans., 2007, 35: 794-796
[28]  Pienta K J, McGregor N, Axelrod R, Axelrod D E. Transl. Oncol., 2008, 1: 158-164
[29]  Kareva I. Transl. Oncol., 2011, 4: 266-270
[30]  Duan S, Yuan W, Wu F, Jin T. Angewandte Chemie, 2012, 51: 7938-7941
[31]  Folkman J. N. Engl. J. Med., 1971, 285: 1182-1186
[32]  Rezaei S J, Nabid M R, Niknejad H, Entezami A A. Int. J. Pharm., 2012, 437: 70-79
[33]  Liu D, Liu F, Liu Z, Wang L, Zhang N. Mol. Pharm., 2011, 8: 2291-2301
[34]  McQuade P, Knight L C, Welch M J. Bioconjug. Chem., 2004, 15: 988-996
[35]  Jubeli E, Moine L, Nicolas V, Barratt G. Int. J. Pharm., 2012, 426: 291-301
[36]  Fogal V, Zhang L, Krajewski S, Ruoslahti E. Cancer Res., 2008, 68: 7210-7218
[37]  Markovsky E, Baabur-Cohen H, Eldar-Boock A, Omer L, Tiram G, Ferber S, Ofek P, Polyak D, Scomparin A, Satchi-Fainaro R. J. Control Release, 2012, 161: 446-460
[38]  Danhier F, Feron O, Preat V. J. Control Release., 2010, 148: 135-146
[39]  Santoro L, Boutaleb S, Garambois V, Bascoul-Mollevi C, Boudousq V, Kotzki P O, Pelegrin M, Navarro-Teulon I, Pelegrin A, Pouget J P. J. Nucl. Med., 2009, 50: 2033-2041
[40]  Zhang Y, Yang M, Park J H, Singelyn J, Ma H, Sailor M J, Ruoslahti E, Ozkan M, Ozkan C. Small, 2009, 5: 1990-1996
[41]  Maeda N, Takeuchi Y, Takada M, Sadzuka Y, Namba Y, Oku N. J. Control Release, 2004, 100: 41-52
[42]  Lu Z X, Liu L T, Qi X R. Int. J. Nanomed., 2011, 6: 1661-1673
[43]  Sugahara K N, Teesalu T, Karmali P P, Kotamraju V R, Agemy L, Girard O M, Hanahan D, Mattrey R F, Ruoslahti E. Cancer Cell, 2009, 16: 510-520
[44]  Garg A, Kokkoli E. Curr. Pharm. Biotechnol., 2011, 12: 1135-1143
[45]  Laakkonen P, Zhang L, Ruoslahti E. Ann. N. Y. Acad. Sci., 2008, 1131: 37-43
[46]  Xin H, Sha X, Jiang X, Zhang W, Chen L, Fang X. Biomaterials, 2012, 33: 8167-8176
[47]  Jain R K. Annu. Rev. Biomed. Eng., 1999, 1: 241-263
[48]  Olive K P, Jacobetz M A, Davidson C J, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben M A, Caldwell M E, Allard D, Frese K K, Denicola G, Feig C, Combs C, Winter S P, Ireland-Zecchini H, Reichelt S, Howat W J, Chang A, Dhara M, Wang L, Ruckert F, Grutzmann R, Pilarsky C, Izeradjene K, Hingorani S R, Huang P, Davies S E, Plunkett W, Egorin M, Hruban R H, Whitebread N, McGovern K, Adams J, Iacobuzio-Donahue C, Griffiths J, Tuveson D A. Science, 2009, 324: 1457-1461
[49]  Li Y, Pan S, Zhang W, Du Z. Nanotechnology, 2009, 20: art. no. 065104
[50]  Pong W W, Gutmann D H. Oncogene, 2011, 30: 1135-1146

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133